Cargando...
Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database
BACKGROUND: Cilostazol has been associated with spontaneous reports of cardiovascular adverse events and serious bleeding. The objective of this study is to determine the relative risk of cardiovascular adverse events or haemorrhages in patients with peripheral artery disease treated with cilostazol...
Guardado en:
| Publicado en: | BMC Cardiovasc Disord |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5941464/ https://ncbi.nlm.nih.gov/pubmed/29739318 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-018-0822-4 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|